Juvenile Inflammatory Rheumatism (JIR) Cohorte (JIR-cohorte)

Michaël Hofer

Status: Invitation-only

Conditions: Arthritis, Juvenile Rheumatoid

Study type: Observational

Funder types: Other

Identifiers

NCT02377245

JIR-001

Details and patient eligibility

About

The investigators created a cohort of patients with juvenile inflammatory rheumatisms with the purpose to follow them prospectively, and investigate the tolerance and efficacy of immunosuppresive and biological agents.

Full description

The JIR-cohort has to be filled by an authorized investigator during or after the consultation. Each patient much be followed at least once a year.

Different data are requested in the JIR-cohort: diagnosis, treatment, adverse events and outcome.

Enrollment: 15,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with juvenile inflammatory diseases
• Age at onset up to 18 years old
• Consent according national codes of ethics and current laws

Exclusion criteria

• Non-consent from patients and/or legal representative

Trial design

15,000 participants in 1 patient group

Juvenile Inflammatory Rheumatism

Description:

Juvenile Inflammatory Rheumatism patients